Pediatric & Adolescent Medicine Translational Research Unit

Pediatric & Adolescent Medicine Translational Research Unit

The Pediatric TRU is a unique unit within Children’s Hospital of Wisconsin. We are located on the second floor of the Center Tower – right behind the information desk. You can find the TRU via the Skywalk and head to the right around the information desk (where Clifford sits) or by taking the R elevators to the 2nd floor.



Research Coordination Support

  • Trainer and consultant
  • IRB Navigation (IRBnet)
  • Budget consultation

  • EPIC research trainer
  • FDA Regulations

Nursing Support

  • Nursing study support
  • Nursing coordination

Other Services

  • Phlebotomy
  • 12 Lead EKG support (not reading/interpreting)
  • Lab spinning and storing of serum, plasma, buffy coat; ability to draw clinical labs at time of the research draw; obtain DNA samples for pick up and processing
  • Specimen shipping – IATA/DOT trained
  • Dedicated exam rooms for study participants
  • Investigation drug administration
  • IV starts
  • Bod Pod and Pea Pod for body composition measurement
  • Ambulatory BP Monitoring equipment
  • Data Entry (REDCap)
  • All RNs are PALS certified nurses

Special Accommodations

To request special accommodations, please contact Beth Gissibl.

Hours of Operation
  • Monday & Wednesday

    7:30am - 4:30pm
  • Tuesday & Thursday

    7:00am - 6:00pm
  • Friday

    7:30am - 4:00pm

Additional requests for services outside these times can be discussed via telephone with Beth Gissibl, Pediatric TRU Manager: (414) 266-3994.

TRU Terms & Attestations

TRU Terms & Attestations


  • The TRU requires a fully signed Letter of Agreement (LOA) and a copy of the Institutional Review Board (IRB) Approval letter before the study may begin.
  • Cancellation of Requested Services: Please provide notice of at least 48 hours for cancellation of requested services. Should short-notice or no-notice cancellations become frequent or habitual we reserve the right to charge for such scheduled services.
  • Scheduling of Requested Services: Availability is to the best of our ability with variables including but not limited to: already scheduled services for this or any other study, availability of appropriate staff, and availability of appropriate physical space.
  • The TRU fees are subject to change. Every effort will be made to minimize the amount and frequency of such changes.
  • Pass through fees from external contractors (ex. external laboratory fees) are subject to change should the external contractor fees change.
  • As a practice, the TRU will keep and maintain copies of all study related documents which will be turned over to the Principal Investigator at the time of study closure.
  • As a CTSI Investigator, you agree to participate in the TRU’s annual satisfaction survey process.
  • Should additional services be requested, a new proposal may be created to outline the scope of the request and associated cost-sharing fees. This LOA will be amended as necessary.
  • If any changes are made in your protocol, it is the study team’s responsibility to provide any updated IRB approved forms and review any procedural changes with the A-TRU Nurse Manager prior to the next participant’s scheduled visit.
  • The TRU will bill on a monthly basis for all services rendered.
  • Payment for services performed will be expected upon receipt of a billing statement. Statements for ongoing services will be submitted on a monthly basis. Payment instructions will be included on the statements. Our Program Associate will be in touch with you to obtain contact information for invoicing.


  • On behalf of the department/division/institute or other professional jurisdiction that you represent, you attest that all of the following conditions have been satisfied:
    • The Principal Investigator is a faculty member, credentialed physician, licensed nurse or licensed pharmacist (as applicable) in good standing;
    • The Principal Investigator is approved to devote the proposed time and effort to this project;
    • If the Principal Investigator’s application identifies Department/Division/Institute funds to support this project, this Department/Division/Institute endorses this commitment;
    • The project has scientific merit, uses procedures consistent with sound research design, and is likely to yield the expected knowledge; and
    • The proposal is a complete and coherent one.
  • You agree to cite the CTSA NIH Grant UL1TR001436 and if applicable KL2TR001438 on all publications arising from any research project receiving support from the CTSI. Publications arising from any research project receiving support from the CTSI must acknowledge such support by stating the following:
    • “Support received by grant UL1TR001436 from the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences.”
    • KL2 Scholars: “Support received by grants UL1TR001436 and KL2TR001438 from the Clinical and Translational Science Award (CTSA) program of the National Center for Advancing Translational Sciences.”

Request Services

Request Services

Please sign in to access this form. If you haven't signed up yet, please join CTSI.

Lost your password?
Contact Us

Contact Us

P-TRU provides a variety of support for both funded and unfunded research. Please contact Beth or Jeff to learn more about how we can meet your needs.

Whether you wish to initiate a study using the TRU, or are considering using the TRU, please contact us to set up a meeting for initial conversations.

Jeffrey Crawford
Research Coordinator
(414) 266-7254

Beth Gissibl
(414) 266-3994

  • This field is for validation purposes and should be left unchanged.

NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.


Zablocki VA Medical CenterMedical College of WisconsinMSOE